Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40002694
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
13/04/2023
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target Thermo Fisher Scientific Inc. commits to reach net-zero greenhouse gas emissions across the value chain by 2050 from a 2018 base year. Near-Term Targets Thermo Fisher Scientific commits to reduce absolute scope 1 and 2 GHG emissions 50.4% by 2030 from a 2018 base year. Thermo Fisher also commits that 90% of its suppliers by spend covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by 2027. Long-Term Targets Thermo Fisher commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2018 base year. Thermo Fisher also commits to reduce absolute scope 3 GHG emissions 90% by 2050 from a 2021 base year.
Statut
Targets setAnnée cible
2050
Statut
BA1.5 memberDate d'engagement
22/07/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US8835561023
LEI
HCHV7422L5HDJZCRFL38
Source : Science Based Targets initiative | Données publiques